Log In
BCIQ
Print this Print this
 

biosimilar certolizumab (PF688)

  Manage Alerts
Collapse Summary General Information
Company Pfenex Inc.
DescriptionBiosimilar of certolizumab, a pegylated humanized antibody fragment against tumor necrosis factor (TNF) alpha
Molecular Target Tumor necrosis factor (TNF) alpha
Mechanism of ActionAntibody; Biosimilar
Therapeutic ModalityBiologic: Antibody
Latest Stage of DevelopmentPreclinical
Standard IndicationRheumatoid arthritis (RA)
Indication DetailsTreat rheumatoid arthritis (RA)
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today